The SPAC’s filing is for an offer one-third less that the $300 million oroginally planned. Aequi is focused on data-centric companies. Read more.
Aequi Files Prelim Prospectus on $200M IPO
Related Posts
Murphy Canyon Acquisition Sets Vote Date on Conduit Pharma Deal
San Diego-based Conduit expects to use proceeds from the deal to accelerate development of its autoimmune disease and idiopathic male infertility pipeline.
Jiya Discloses $5M Private Placement
In tandem with its $100 million IPO, the biopharma-focused SPAC said it has an agreement with sponsor Jiya Holding Company for the sponsor to buy 500,000 shares.
Poema Upsizes IPO 20% to $300M
"Our geographic focus is global in nature, but with a particular focus on business combination targets in Europe and Asia," the SPAC said in a filing.
Subversive Capital Announces 70% Upsize Of Private Placement to $63M
The non-brokered private placement is an upsize of more than 70 percent from the $36.5 million announced previously.